Tenax Therapeutics

TENXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$72.602 M

$1.94 +3.19%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$52.6M

Loss-making

Shares outstanding

37,423,917

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#328Connect BiopharmaCNTB$76.5M
#329CingulateCING$74.8M
#330Tenax TherapeuticsTENX$72.6M
#331Gossamer BioGOSS$71.5M
#332Pliant TherapeuticsPLRX$70.6M

What if Tenax Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$807,878.28

Per share 416,432× higher

Bitcoin $1.74T

$46,538.56

Per share 23,989× higher

Nvidia $5.52T

$147,386.15

Per share 75,972× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Tenax Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.